Cameron Tammy 4
4 · DEPOMED INC · Filed May 13, 2011
Insider Transaction Report
Form 4
DEPOMED INCDEPO
Cameron Tammy
VP, Finance
Transactions
- Exercise/Conversion
Common Stock
2011-05-11$1.98/sh+30,000$59,400→ 40,054 total - Exercise/Conversion
Common Stock
2011-05-11$1.83/sh+17,742$32,468→ 27,796 total - Exercise/Conversion
Common Stock
2011-05-12$1.83/sh+18,821$34,442→ 28,875 total - Sale
Common Stock
2011-05-11$8.61/sh−30,000$258,360→ 10,054 total - Sale
Common Stock
2011-05-11$8.36/sh−17,742$148,270→ 10,054 total - Sale
Common Stock
2011-05-12$8.26/sh−18,821$155,367→ 10,054 total - Exercise/Conversion
Stock Option
2011-05-11−30,000→ 0 totalExercise: $1.98Exp: 2017-08-24→ Common Stock (30,000 underlying) - Exercise/Conversion
Stock Option
2011-05-11−17,742→ 47,258 totalExercise: $1.83Exp: 2019-01-23→ Common Stock (17,742 underlying) - Exercise/Conversion
Stock Option
2011-05-12−18,821→ 28,437 totalExercise: $1.83Exp: 2019-01-23→ Common Stock (18,821 underlying)
Footnotes (5)
- [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.53 to $8.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.35 to $8.38. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.25 to $8.28. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
- [F4]Exercisable on 8/24/2008 with respect to 50% of the underlying shares and monthly thereafter.
- [F5]Exercisable in 48 equal monthly installments.